Phase II Study of an AKT Inhibitor MK2206 in Patients With Relapsed or Refractory Lymphoma

Blood - United States
doi 10.1182/blood.v124.21.3093.3093
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy